
Lotus Bio-Technology Development Corp. Share · US54570R1077 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Lotus Bio-Technology Development Corp.
No Price
Closing Price OTC 30.04.2026:
0,01 USD
30.04.2026 20:00
Current Prices from Lotus Bio-Technology Development Corp.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
LBTD
|
USD
|
30.04.2026 20:00
|
0,01 USD
| 0,00 USD |
Company Profile for Lotus Bio-Technology Development Corp. Share
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona.
Company Data
Name Lotus Bio-Technology Development Corp.
Company Lotus Bio-Technology Development Corp.
Website
http://www.lbtdholdings.com
Primary Exchange
UTC
ISIN US54570R1077
Asset Class Share
Sector Basic Materials
Industry Agricultural Inputs
CEO Hoyt Christopher
Country United States of America
Currency USD
Employees -
Address 28202 North 58th Street, 85331 Cave Creek
IPO Date 2014-04-22
Stock Splits
| Date | Split |
|---|---|
| 26.06.2014 | 30:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | LBTD |
More Shares
Investors who hold Lotus Bio-Technology Development Corp. also have the following shares in their portfolio:

